Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Emerging options with coxib therapy.

Mark J Lema1

  • 1Department of Anesthesiology, State University of New York at Buffalo School of Medicine, USA. mlema@acsu.buffalo.edu

Cleveland Clinic Journal of Medicine
|June 28, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What's new in chronic pain pathophysiology.

Canadian journal of pain = Revue canadienne de la douleur·2021
Same author

World medical leaders declare that pain treatment is a human right … and it couldn't come at a worse time.

Pain medicine (Malden, Mass.)·2012
Same author

Creating a culture of civility takes a team.

AORN journal·2011
Same author

Types and epidemiology of cancer-related neuropathic pain: the intersection of cancer pain and neuropathic pain.

The oncologist·2010
Same author

NSAIDs and cardiovascular risk.

Cell metabolism·2005
Same author

Anaesthetic team and the role of nurses--North American perspective.

Best practice & research. Clinical anaesthesiology·2002
Same journal

A 20-year-old woman with a 9-year history of shortness of breath.

Cleveland Clinic journal of medicine·2026
Same journal

A 70-year-old man with lower-extremity weakness and falls.

Cleveland Clinic journal of medicine·2026
Same journal

Treatment-refractory hypothyroidism: Don't just increase the dose.

Cleveland Clinic journal of medicine·2026
Same journal

In Reply: Beyond histologic improvement in MASH.

Cleveland Clinic journal of medicine·2026
Same journal

Comfort care: Creating a plan for hospitalized patients and their families.

Cleveland Clinic journal of medicine·2026
Same journal

Localized dead bone, a potential hint to an underlying condition.

Cleveland Clinic journal of medicine·2026
See all related articles

Cyclooxygenase-2 selective inhibitors (coxibs) show potential beyond arthritis pain relief. Research is exploring their use in Alzheimer's disease treatment and colorectal cancer prevention, with promising preliminary results.

Area of Science:

  • Pharmacology
  • Oncology
  • Neurology

Background:

  • Cyclooxygenase-2 (COX-2) selective inhibitors (coxibs) are currently used for arthritis pain.
  • Inflammatory mechanisms are implicated in Alzheimer's disease (AD) neurodegeneration.
  • Coxibs are being investigated for chemopreventive benefits in colorectal cancer (CRC).

Purpose of the Study:

  • To explore the extended clinical applications of coxibs.
  • To evaluate the efficacy of coxibs in Alzheimer's disease.
  • To assess the chemopreventive potential of coxibs in colorectal cancer.

Main Methods:

  • Review of epidemiological surveys, preclinical studies, and clinical trials.
  • Ongoing clinical trials investigating coxibs' effect on AD progression.

Related Experiment Videos

  • Studies on tumor cell lines, animal, and human models for CRC chemoprevention.

    • Main Results:

    • Preliminary evidence suggests a role for inflammatory mechanisms in AD.
    • Coxibs demonstrate potential to promote apoptosis and inhibit angiogenesis in CRC.
    • Coxibs offer an opioid-sparing effect in cancer pain management without significant adverse effects.

    Conclusions:

    • Coxibs may offer therapeutic benefits in Alzheimer's disease.
    • Coxibs show promise as chemopreventive agents for colorectal cancer.
    • Coxibs are valuable in palliative care for cancer pain management.